Institutional Ownership Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR). We have compiled data on the 183 institutions that hold shares in the stock, with a total of 106 Million shares, which have been reported (via 13F filing form) to have a value of $268 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
603,775
shares
|
$1.57 Million
0.0% of portfolio
|
Q2 2025
Added 235.01%
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
493,929
shares
|
$1.28 Million
0.0% of portfolio
|
Q2 2025
Added 93.33%
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
485,603
shares
|
$1.26 Million
0.0% of portfolio
|
Q2 2025
Added 238.31%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
452,650
shares
|
$1.18 Million
0.0% of portfolio
|
Q2 2025
Reduced 52.9%
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
422,613
shares
|
$1.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 86.31%
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
393,290
shares
|
$1.02 Million
0.0% of portfolio
|
Q2 2025
Added 2866.88%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
361,709
shares
|
$940,443
0.0% of portfolio
|
Q2 2025
Added 53.18%
|
|
Summit Wealth Group, LLC
White River Junction, VT |
Aug 06, 2025 Q2 2025 |
323,000
shares
|
$839,800
0.08% of portfolio
|
Q2 2025
Added 10.24%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
292,400
shares
|
$760,240
0.0% of portfolio
|
Q2 2025
New holding
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
279,760
shares
|
$727,376
0.0% of portfolio
|
Q2 2025
Added 75.66%
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
275,688
shares
|
$716,788
0.0% of portfolio
|
Q2 2025
Added 16.8%
|
|
Prelude Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
265,588
shares
|
$690,528
0.03% of portfolio
|
Q2 2025
Added 57.8%
|
|
Highbridge Capital Management LLC
New York, NY |
May 12, 2025 Q1 2025 |
254,265
shares
|
$661,089
0.08% of portfolio
|
Q2 2024
New holding
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
249,500
shares
|
$648,700
0.0% of portfolio
|
Q2 2025
New holding
|
|
Simplex Trading, LLC
|
Aug 05, 2025 Q2 2025 |
230,463
shares
|
$599,203
0.0% of portfolio
|
Q2 2025
Added 57.05%
|
|
Group One Trading, L.P.
Chicago, IL |
Aug 13, 2025 Q2 2025 |
228,125
shares
|
$593,125
0.01% of portfolio
|
Q2 2025
Added 52.37%
|
|
Davidson Kempner Capital Management LP
New York, NY |
Aug 14, 2025 Q2 2025 |
222,482
shares
|
$578,453
0.01% of portfolio
|
Q1 2023
New holding
|
|
Squarepoint Ops LLC
New York, NY |
Aug 27, 2025 Q2 2025 |
214,386
shares
|
$557,403
0.0% of portfolio
|
Q2 2025
Reduced 75.57%
|
|
Nj State Employees Deferred Compensation Plan
|
Aug 05, 2025 Q2 2025 |
195,125
shares
|
$507,325
0.02% of portfolio
|
Q1 2023
Added 1827.16%
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
184,367
shares
|
$479,354
0.0% of portfolio
|
Q2 2025
Added 197.91%
|
|
Pentwater Capital Management LP
Naples, FL |
Aug 14, 2025 Q2 2025 |
181,290
shares
|
$471,354
0.0% of portfolio
|
Q2 2024
New holding
|
|
Umb Bank, N.A.
|
Jul 11, 2025 Q2 2025 |
170,000
shares
|
$442,000
0.0% of portfolio
|
Q2 2025
New holding
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
134,514
shares
|
$349,736
0.0% of portfolio
|
Q2 2025
Added 7.14%
|
|
Parallel Advisors, LLC
|
Jul 07, 2025 Q2 2025 |
127,424
shares
|
$331,302
0.0% of portfolio
|
Q2 2025
Added 1174.24%
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
123,448
shares
|
$320,964
0.0% of portfolio
|
Q2 2025
Reduced 89.86%
|